clock menu more-arrow no yes

Filed under:

Reports: David Lopez deal agreed with Espanyol, medical coming tomorrow

New, comments

This deal continues to tick along quickly, with a deal reportedly agreed between the clubs and the player soon en route to Naples for a medical.

Shame he can't play tonight, he locked down Muniain last season.
Shame he can't play tonight, he locked down Muniain last season.
David Ramos

According to reports in Spain, Napoli and RCD Espanyol have come to an agreement on terms for the purchase of midfielder David Lopez.

The deal, believed to be for the same €5 million discussed yesterday, will see Lopez in a Napoli kit very soon, with a medical believed to be coming tomorrow (though Radio Kiss Kiss denied that, albeit in a fashion that felt like the club not wanting to deflect attention from tonight's Champions League tie). That suggests that, as long as everything goes smoothly with the medical, Lopez could be officially a Napoli player by the end of the week.

Lopez is reportedly to receive a five year contract and while wages are obviously undisclosed, even a significant bump from what he was making in Spain won't be particularly high wages for Napoli. The term is long, but helps spread out his Financial Fair Play impact to a negligible level thanks to his low fee and wages, and at his age and talent, keepinh Lopez around that long is no imposition at all.

There are five days left in the transfer window after today. If Napoli win tonight and secure a group stage berth, expect a couple more deals to materialize to reinforce the squad once that extra bit of financial security is there. Even if they don't, you could see a flurry of activity, but it would likely involve the departure of a few liked players and bringing in younger talents to replace them or fill other holes in the squad.

In any case, hopefully we'll be able to welcome Lopez to Napoli soon. He's a good player and an excellent fit for what the club is trying to do, and hopefully he'll have a long and successful career here.